Nintedanib bei progressiver Nicht-IPF-Lungenfibrose – eine SubgruppenanalyseNintedanib in progressive non-IPF pulmonary fibrosis—A subgroup analysis

被引：0
|
作者：
Philipp Markart
机构：
[1] Universitätsmedizin Marburg,Medizinische Klinik V (Pneumologie), Herzthoraxzentrum, Klinikum Fulda gAG
[2] Campus Fulda,Medizinische Klinik und Poliklinik II
[3] Universitätsklinikum Gießen und Marburg GmbH,undefined
[4] Standort Gießen,undefined
来源：
Der Pneumologe | 2020年 / 17卷 / 5期
关键词：
D O I：
10.1007/s10405-020-00341-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：350 / 351
页数：1
相关论文
共 41 条
  • [1] Nintedanib in progressive Non-IPF-Pulmonary Fibrosis - A Subgroup Analysis
    Markart, Philipp
    PNEUMOLOGE, 2020, 17 (05): : 350 - 351
  • [2] Real-world of Nintedanib in a Spanish non-IPF progressive pulmonary fibrosis cohort
    Vicens Zygmunt, Vanesa
    Bordas-Martinez, Jaume
    Munoz-Bolano, Miriam
    Carmezim-Correia, Joao
    Belen Llanos-Gonzalez, Ana
    Domingo-Carnice, Adria
    Rodriguez-Cumplido, Dolores
    Bermudo-Peloche, Guadalupe
    Tebe-Cordomi, Cristian
    Llop-Rius, Roser
    Molina-Molina, Maria
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [3] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    Finnerty, James Patrick
    Ponnuswamy, Aravind
    Dutta, Prosjenjit
    Abdelaziz, Ammar
    Kamil, Hafiz
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [4] Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
    James Patrick Finnerty
    Aravind Ponnuswamy
    Prosjenjit Dutta
    Ammar Abdelaziz
    Hafiz Kamil
    BMC Pulmonary Medicine, 21
  • [5] Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study
    Raman, Lavanya
    Stewart, Iain
    Barratt, Shaney L.
    Chua, Felix
    Chaudhuri, Nazia
    Crawshaw, Anjali
    Gibbons, Michael
    Hogben, Charlotte
    Hoyles, Rachel
    Kouranos, Vasilis
    Martinovic, Jennifer
    Mulholland, Sarah
    Myall, Katherine J.
    Naqvi, Marium
    Renzoni, Elisabetta A.
    Saunders, Peter
    Steward, Matthew
    Suresh, Dharmic
    Thillai, Muhunthan
    Wells, Athol U.
    West, Alex
    Mitchell, Jane A.
    George, Peter M.
    ERJ OPEN RESEARCH, 2023, 9 (02)
  • [6] Multicenter real-world data of antifibrotics in non-IPF progressive pulmonary fibrosis (PPF) patients
    Ocal, Nesrin
    Cilli, Aykut
    Bishop, Nesrin Mogulkoc
    Coskun, Funda
    Ursavas, Ahmet
    Hanta, Ismail
    Ozyurek, Berna Akinci
    Ensarioglu, Kerem
    Erzincan, Alper
    Yuksel, Esra
    Arikan, Beste
    Uzer, Fatih
    Ozdemirel, Tugce Sahin
    Misirci, Salim
    Deniz, Pelin Pinar
    Basyigit, Ilknur
    Kumbasar, Ozlem Ozdemir
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [7] MULTICENTER STUDY INVESTIGATING THE IMPACT OF DEEP LEARNING-BASED UIP CLASSIFIER ON IDENTIFYING UNDIAGNOSED IPF AND NON-IPF PROGRESSIVE PULMONARY FIBROSIS
    Patel, Avignat
    Bhatt, Padmanabh
    Thomas, Richard
    Hoang, Hai
    Aglan, Mostafa
    Ahmed, Alaaeldin
    Arora, Shreya
    Vaz, Victor Ren
    Guillen, Ramon
    Wald, Christoph
    Rieger-Christ, Kimberly
    Liesching, Timothy N.
    Pinto-Plata, Victor M.
    Thomson, Carey C.
    Gazourian, Lee
    CHEST, 2024, 166 (04) : 6398A - 6399A
  • [8] MMP28 Is Upregulated in Idiopathic Pulmonary Fibrosis (IPF) Epithelium and Is a Promising Biomarker to Distinguish IPF from Non-IPF Patients
    Maldonado, M.
    Buendia, I.
    Vicens Zygmunt, V.
    Planas, L.
    Molina Molina, M.
    Selman, M.
    Pardo, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [9] A real-life cohort of antifibrotic-treated non-IPF progressive pulmonary fibrosis patients
    Renner, A.
    Vertanen, E.
    Sutinen, E.
    Ainola, M.
    Myllaerniemi, M.
    Hollmen, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S552 - S552
  • [10] Meta-analysis of effect of nintedanib on mortality in subjects with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis (PPF)
    Koschel, D.
    Wuyts, W.
    Maher, T.
    Wijsenbeek, M.
    Martinez, F.
    Stansen, W.
    Stowasser, S.
    Richeldi, L.
    PNEUMOLOGIE, 2024, 78 : S81 - S82
12345